In hepatocellular carcinoma, TKT exerts an inhibitory effect on STAT3-S727 phosphorylation and activator effect on STAT3-Y705 phosphorylation, respectively [24]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.